Personal Wealth Partners Bristol Myers Squibb CO Transaction History

Personal Wealth Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $299,847 - $330,237	-4,129 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $7,737 - $8,767	-134 Reduced 3.14%	4,129 $256,000
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $2,137 - $2,499	-39 Reduced 0.91%	4,263 $251,000
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $1,919 - $2,503	39 Added 0.91%	4,302 $276,000
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $5,731 - $6,795	134 Added 3.25%	4,263 $216,000
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $5,979 - $6,611	-134 Reduced 3.14%	4,129 $187,000
Q1 2019 Apr 17, 2019	SELL	$45.12 - $53.8 $10,558 - $12,589	-234 Reduced 5.2%	4,263 $203,000
Q4 2018 Feb 05, 2019	BUY	$48.76 - $63.23 $219,273 - $284,345	4,497 New	4,497 $234,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Personal Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Personal Wealth Partners with notifications on news.